| TEMPUS AI INC. DL-,01 |
| USA |
| Gesundheit |
| US88023B1035 / A40EDP |
| F3M (Frankfurt) / TEM (NASDAQ) |
| FRA:F3M, ETR:F3M, F3M:GR, NASDAQ:TEM |
| - |
| https://www.tempus.com/ |
|
Tempus AI, Inc. is a healthcare technology company that applies artificial intelligence and machine learning to clinical and molecular data to support medical decision-making. The company operates a data and analytics platform designed to structure, ..
>Volltext.. |
| 8411.97 Mio. EUR |
| 9000.17 Mio. EUR |
| 1192.51 Mio. EUR |
| -129.07 Mio. EUR |
| -264.79 Mio. EUR |
| -1.5 EUR |
| 1152.61 Mio. EUR |
| 455.59 Mio. EUR |
| -162.57 Mio. EUR |
| 2.01 |
| 59.01% |
| 60% |
| - |
| - |
| - |
| 4 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 11.259.818 Euro. |
| TEMPUS AI, TEMPUS AI′S, TEMPUS AI S |
| 21.07.26 |
|
||||
|